ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1372	National Cancer Institute	Html	en	Prostate Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for prostate cancer.	stage prostate cancer 0.41534 prostate cancer families 0.421963 Prostate cancer histologic 0.416191 prostate cancer death 0.461069 prostate cancer-specific mortality 0.450231 prostate cancer detection 0.469664 occult prostate cancer 0.443862 cumulative prostate cancer 0.443087 Prostate Cancer Prostatic 0.422226 clinically localized prostate 0.413378 prostate cancer incidence 0.469487 prostate cancer risk 0.463531 prostate specific antigen 0.460602 Natl Cancer Inst 0.507286 prostate cancer conundrum 0.415161 organ-confined prostate cancer 0.420237 Prostate Cancer Prevention 0.415424 prostate cancers 0.438581 incidental prostate cancer 0.422784 prostate cancer incidents 0.441917 age-adjusted prostate cancer 0.427473 National Prostate Cancer 0.437284 prostate biopsy 0.439547 prostate cancer deaths 0.439576 Prostate Cancer Group 0.440788	recent prostate cancer 0.414693 Localized Prostate Cancer 0.420799 prostate cancer mortality 0.720857 background prostate cancer 0.428331 Cancer Society-National Prostate 0.419744 prostate cancer cases 0.433809 early prostate cancer 0.423859 increase prostate cancer 0.419618 prostate cancer susceptibility 0.420924 Prostate Cancer Treatment 0.436062 decreases prostate cancer 0.418061 prostate cancer diagnosis. 0.428017 Abstract 0.431496 Prostate Cancer Register 0.417403 prostate cancer survival 0.421804 prostate cancer diagnosis 0.475983 prostate cancer screening 0.57009 prostate cancer 0.946722 Finnish prostate cancer 0.414198 low-risk prostate cancer 0.432239 prostate cancer death. 0.426919 Population-based Prostate Cancer 0.418712 early-stage prostate cancer 0.444191 prostate cancer recurrence 0.415556	CLICK HERE
1730	National Cancer Institute	Html	en	Blood-Forming Stem Cell Transplants	A fact sheet that explains the step-by-step procedures of two types of transplantations used with high-dose chemotherapy, including their risks and benefits.	red blood cells 0.400014 cancer treatment 0.26536 cord blood 0.408194 public cord blood 0.298389 bone marrow cells 0.392639 cord blood bank 0.313292 embryonic stem cells 0.414015 cord stem cells 0.382315 healthy cells 0.309763 bone marrow donation 0.293131 white blood cells 0.53145 transplanted stem cells 0.39836 HLA-matched stem cells 0.374986 clinical trials 0.346744 healthy stem cells 0.372316 stem cells 0.95315 stem cell transplant 0.291072 multiple myeloma 0.26697 Bone marrow aspiration 0.292859 cord blood banks 0.343333 immature cells 0.319355 HLA antigens 0.259199 appropriate unrelated donor 0.262231 radiation therapy 0.329306 transplantation 0.292216	blood-forming stem cells 0.415789 immature nerve cells 0.328089 Large volunteer donor 0.262362 new blood cells 0.334223 blood stem cell 0.339528 cancer cells 0.404042 special blood test 0.260646 peripheral blood stem 0.362146 anticancer drugs 0.263549 donor 0.356002 PBSCT 0.299118 patient 0.341681 marrow’s ability 0.258871 blood stem cells 0.413585 healthy bone marrow 0.302284 umbilical cord blood 0.366965 umbilical cord 0.389737 harvested cells 0.30119 commercial cord blood 0.270418 Marrow Donor Program® 0.288844 BMT 0.322432 bone marrow 0.850438 autologous transplant 0.272369 hematopoietic stem cells 0.478378	CLICK HERE
1734	National Cancer Institute	Html	en	Diethylstilbestrol (DES) and Cancer	A fact sheet about DES (a synthetic form of estrogen) and the health problems of children who were exposed to DES while in the womb.	DES grandsons 0.538814 Hatch EE 0.382563 DES exposure 0.67711 Cell Cancer Registry 0.421337 pregnant women 0.436903 mothers 0.380607 Pap test 0.370345 researchers 0.371735 pregnancy 0.387046 slightly increased risk 0.395077 DES Follow-up Study 0.632841 DES-exposed women 0.392223 health problems 0.418784 slightly higher risk 0.374572 prenatal DES exposure 0.579068 hormone replacement therapy 0.402773 possible health effects 0.424124 health effects 0.485372 women 0.613207 DES daughters 0.874038 abnormal cells 0.390363 overall cancer risk 0.3987 prenatally exposed men 0.392794 regular breast cancer 0.374945	Hormonal Transplacental Carcinogenesis 0.419307 third-generation daughters 0.375828 DES-exposed daughters 0.446699 adverse health effects 0.420665 clear cell adenocarcinoma 0.541335 unexposed women 0.492521 DES granddaughters 0.631672 studies 0.380945 National Cancer Institute 0.372742 Military medical records 0.370524 higher risk 0.376562 breast cancer risk 0.433356 breast cancer 0.508269 birth defects 0.404912 cervical intraepithelial neoplasia 0.371506 DES-exposed mothers 0.370151 DES 0.962997 squamous intraepithelial lesions 0.371888 abnormal cell changes 0.370094 Clear Cell Cancer 0.418711 et al 0.459666 New England Journal 0.400964 cancer 0.517317 risk 0.491261	CLICK HERE
1899	National Cancer Institute	Html	es	Tratamiento del cáncer de esófago (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de esófago.	pequeñas incisiones 0.23384 siguientes procedimientos 0.284377 estadio iv 0.901829 siguientes aspectos 0.246993 cirugía.ampliar cáncer 0.384736 tumor.ampliar cáncer 0.927954 esófago.ampliar cáncer 0.406819 superior.ampliar ingesta 0.240636 rayos x 0.233574 estadio ib 0.846212 estadio ia 0.848718 enlace drugs approved 0.225674 cuerpo.ampliar adenocarcinoma 0.237712 ondas sonoras 0.23487 tumor.ampliar adenocarcinoma 0.237933 carcinoma epidermoide 0.253815 National Cancer Institute 0.207996 oampliar adenocarcinoma 0.284398	Instituto Nacional 0.217897 estadio iiia 0.772409 PDQ Tratamiento 0.210664 estadio iiic 0.728279 raras ocasiones 0.236561 estadio iiib 0.520728 estadio iia 0.995304 estadio iib 0.810094 Physician Data Query 0.236785 haz angosto 0.214315 pequeña incisión 0.215302 cirugía.ampliar adenocarcinoma 0.240417 Esophageal Cancer 0.21336 crecimiento her2 0.212549 3.ampliar adenocarcinoma 0.246955 cuerpo.ampliar cáncer 0.373348 siguientes pruebas 0.298459	CLICK HERE
1981	National Cancer Institute	Html	es	Etapa final de la vida (PDQ®)–Versión para pacientes	Sumario informativo revisado por expertos sobre el tratamiento y la atención del paciente de cáncer desde los últimos días hasta las últimas horas de vida; esto incluye los síntomas comunes, los dilemas éticos que pueden surgir y la función que desempeña el oncólogo en proveer cuidados al paciente y su familia durante este período.	etapa final 0.952722 alientoLa sensación 0.303004 siguientes afecciones 0.302215 Mejor comunicación 0.301527 posibles daños 0.30146 Contracciones mioclónicasLas 0.30427 siguientes tipos 0.302214 PDQ Aflicción 0.302895 PDQ Etapa final 0.30437 suficiente oxígeno 0.302526 HemorragiaLa hemorragia 0.303897 vía rectal 0.302425 obstructiva crónica 0.302498 posibles riesgos 0.304519 efectos directos 0.302483 vías respiratorias 0.375323 muerteEl estertor 0.304331 National Cancer Institute 0.30139 especial cánceres 0.30221 Mejor alivio 0.301759 próximas horas 0.302343	Instituto Nacional 0.302514 PDQ Planificar 0.312661 contracciones súbitas 0.303377 pequeñas cantidades 0.302149 importantes beneficios 0.301883 cuánta probabilidad 0.301726 Physician Data Query 0.305159 LíquidosLos pacientes 0.308282 PDQ Fatiga 0.306846 FatigaLa fatiga 0.303104 PDQ Delirium 0.307935 término instrucciones 0.301507 posibles beneficios 0.301551 nutrición parenteral 0.304251 reanimación cardiorrespiratoria 0.301653 causa sufrimiento 0.302836 Mejor perspectiva 0.301742 sufrimiento extremo 0.306751 numerosos cambios 0.308661 ReanimaciónLos pacientes 0.308108	CLICK HERE
15713	National Cancer Institute	Html	es	Desigualdades por cáncer	Información básica de las desigualdades por cáncer en EE. UU., factores que contribuyen a la carga desproporcionada del cáncer en algunos grupos y ejemplos de desigualdades en incidencia y mortalidad entre ciertos grupos de la población.	excesivo consumo 0.503273 enfermedad llamada 0.433789	Estados Unidos 0.991629	CLICK HERE
16297	National Cancer Institute	Html	en	Medicinal Mushrooms (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of medicinal mushrooms as a treatment for people with cancer.	G. lucidum products 0.573204 adjuvant chemotherapy 0.660268 PSK-treated group 0.523648 class I–negative patients 0.557926 control group 0.693917 humoral immune parameters 0.519217 Baseline immune parameters 0.519968 PDQ cancer information 0.546523 lung cancer 0.659292 investigators 0.524722 natural killer 0.558674 turkey tail 0.569981 innate immune cells 0.545469 advanced gastric cancer 0.572653 doxorubicin -based chemotherapy 0.54683 patients 0.832482 cancer patients 0.665826 G. lucidum 0.844684 gastric cancer patients 0.617385 PSK 0.985645 adjuvant therapy 0.585553 standard cancer treatments 0.5637 G. lucidum fruit 0.543411 cancer patient plasma 0.523542	radiation therapy 0.5502 lung cancer models 0.542252 medicinal mushrooms 0.540839 protein-bound PSK 0.737238 immune response pathways 0.537187 lung cancer cohort. 0.537885 PSK recipients 0.737199 PSK adjuvant immunotherapy 0.863333 PSK group 0.883506 advanced lung cancer 0.536376 G. lucidum polysaccharides 0.77527 advanced colorectal cancer 0.532494 National Cancer Institute 0.545709 5-year survival 0.544251 direct antitumor mechanisms 0.520707 lung cancer patients 0.596507 PSK patients 0.803579 adjuvant PSK 0.861863 gastric cancer 0.807983 G. lucidum enhance 0.535434 direct antitumor 0.521271 PSK treatment 0.759609 5-year survival rates 0.518116 MHC expression–negative patients 0.571654	CLICK HERE
16562	National Cancer Institute	Html	en	Screen to Save: NCI Colorectal Cancer Outreach and Screening Initiative	NCI Colorectal Cancer Outreach and Screening Initiative aims to increase colorectal cancer screening rates among ethnically and racially diverse and rural communities nationwide.	NCI-designated Cancer Centers 0.680452 country 0.523395 evidence-based resources 0.584437 education 0.537172 National Cancer Advisory 0.70446 Alaskan Natives 0.584304 recommendations 0.526636 overall assessment 0.573123 ethnically diverse communities 0.720461 local communities 0.586899 colorectal screening rates 0.853048 outreach activities 0.578711 colorectal cancer screening 0.850894 rural areas 0.584762 colorectal cancer 0.992617 Cancer Control National 0.675464 PACHE-funded community health 0.657281 community levels 0.588626 National Outreach Network 0.661026 Health Disparities Program 0.668335 women age 0.582977 Reduce Cancer Health 0.704459 American Indians 0.579831 Colorectal Cancer Awareness 0.761387	Cancer Moonshot 0.620655 Cancer Health Disparities 0.821429 NCI Center 0.608436 Blacks/African Americans 0.579578 Save initiative 0.611204 Cancer Health Equity 0.685373 NCI Colorectal Cancer 0.830393 Regional Coordinating Directors 0.639583 diverse partner network 0.664475 Blue Ribbon Panel 0.662084 rural communities 0.646304 Geographic Management 0.573805 community health educators 0.957975 outreach efforts 0.576306 Native Hawaiians 0.58859 screening resources 0.639461 Pacific Islanders 0.584476 evidence-based colorectal cancer 0.788139 key role 0.575779 colorectal screening behaviors 0.792179 NCI-approved colorectal cancer 0.776303 additional community engagements 0.645113 Screening Initiative 0.658551 information 0.537846	CLICK HERE
17189	National Cancer Institute	Html	en	Sexual Health Issues in Women with Cancer	Cancer treatments such as chemotherapy, hormone therapy, and radiation may cause sexual problems in women. Conditions may include vaginal dryness, vaginal stenosis, and vaginal atrophy. Learn how to manage and treat these sexual problems.	cancer treatment 0.51645 vaginal tissue 0.532819 primary ovarian insufficiency 0.548774 endocrine therapy 0.478386 health care team 0.776749 sexual life 0.612375 support group 0.540233 gynecologic cancers 0.477639 social worker 0.530013 pelvic muscles 0.474973 sexual activity 0.559668 sexual health 0.668647 sexual intercourse 0.555683 low estrogen levels 0.65848 hair loss 0.473268 physical changes 0.478751 birth control 0.564552 Fertility Issues 0.55759 effects 0.479305 sexual problems 0.5327 hot flashes 0.548172 radiation therapy 0.542011 long term 0.480571 valuable suggestions 0.473342 vaginal dryness 0.649951	vaginal gels 0.527917 problems 0.541005 women 0.505517 cancer treatments 0.472282 treatment 0.973526 sex life 0.471664 personal health factors 0.547006 vaginal secretions 0.525892 cancer-related support services 0.536181 changes 0.511207 Vaginal stenosis 0.532538 vaginal wall 0.531486 vaginal atrophy 0.531565 hormone therapy 0.536753 sexual changes 0.501579 bladder retention 0.472634 shorter vagina 0.48061 sexual health expert 0.553722 support groups 0.47572 Breast Cancer 0.475837 doctor 0.494029 bowel function 0.475187 national organizations 0.470856 time 0.509374	CLICK HERE
17290	National Cancer Institute	Html	es	Uso extraoficial de medicamentos en el tratamiento del cáncer	Conozca qué es el uso extraoficial o no indicado de medicamentos y el papel que desempeña en el tratamiento del cáncer.	régimen r-cvp 0.716896 régimen cmf 0.714486 régimen beacopp 0.710604 amplio uso 0.781419	Estados Unidos 0.77621 seguro médico 0.921249 siguientes razones 0.728265 régimen tac 0.710628	CLICK HERE